Literature DB >> 25114867

Inflammatory breast cancer clusters: A hypothesis.

Paul H Levine1, Salman Hashmi1, Ashley A Minaei1, Carmela Veneroso1.   

Abstract

Cancer clusters have long been a focus of interest because of the possibility of identifying etiologic agents. Only on rare occasions, however, have such cluster investigations been successful. One major difficulty in cluster investigations, particularly in the area of breast cancer, is the long latent period. There have been a number of publications providing a discouraging picture regarding cancer cluster investigations. The possibility of learning from a cluster investigation, however, is greatly increased if the cancer involved is relatively rare and if it has a short latent period. Inflammatory breast cancer (IBC) fits these criteria and is worth pursuing because of the strong evidence that environmental factors play a major role. In this report we describe our experience with several clusters and the lessons learned which are now being utilized to improve investigation of future IBC clusters. The first IBC cluster that we evaluated was in 2000, when we were asked to investigate an apparent cluster of IBC in Castro Valley, California where three women in an office setting of 24 people were diagnosed with IBC in a ten month period from May 1999 to March 2000. Our investigation of this striking cluster did not yield a specific trigger for this cluster but it did indicate that the women involved all had at least two IBC risk factors that may well have made them susceptible to getting IBC. We are now investigating another apparent cluster in Texas and are aware of several others requiring careful consideration. We see a need for a consistent protocol for the evaluation of IBC clusters focusing on the laboratory investigation of environmental triggers, primarily infectious agents and chemical carcinogens.

Entities:  

Keywords:  Environmental; Infectious agents; Inflammatory breast cancer; Toxins

Year:  2014        PMID: 25114867      PMCID: PMC4127623          DOI: 10.5306/wjco.v5.i3.539

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  40 in total

1.  Epidemic neuromyasthenia; clinical syndrome.

Authors:  D A HENDERSON; A SHELOKOV
Journal:  N Engl J Med       Date:  1959-04-09       Impact factor: 91.245

Review 2.  Inflammatory breast cancer in Tunisia: epidemiological and clinical trends.

Authors:  Hamouda Boussen; Hatem Bouzaiene; Jamel Ben Hassouna; Tarek Dhiab; Fathi Khomsi; Farouk Benna; Amor Gamoudi; Nejib Mourali; Monia Hechiche; Khaled Rahal; Paul H Levine
Journal:  Cancer       Date:  2010-06-01       Impact factor: 6.860

3.  Axillary vein thrombosis as the first clinical manifestation of inflammatory breast cancer: report of a case.

Authors:  Raffaele Serra; Gianluca Buffone; Rossella Montemurro; Stefano de Franciscis
Journal:  Surg Today       Date:  2012-05-23       Impact factor: 2.549

4.  Evaluating cluster alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico.

Authors:  M Kulldorff; W F Athas; E J Feurer; B A Miller; C R Key
Journal:  Am J Public Health       Date:  1998-09       Impact factor: 9.308

5.  Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancer.

Authors:  Paul H Levine; Chia C Portera; Heather J Hoffman; Sherry X Yang; Mikiko Takikita; Quyen N Duong; Stephen M Hewitt; Sandra M Swain
Journal:  Clin Breast Cancer       Date:  2012-06-12       Impact factor: 3.225

6.  Male breast cancer manifesting as cephalic vein thrombosis.

Authors:  Raffaele Serra; Gianluca Buffone; Paolo Perri; Maria Renne; Bruno Amato; Stefano de Franciscis
Journal:  Ann Vasc Surg       Date:  2013-08-26       Impact factor: 1.466

Review 7.  A comparative review of systemic and neurological symptomatology in 12 outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis.

Authors:  N C Briggs; P H Levine
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

8.  An approach to studies of cancer subsequent to clusters of chronic fatigue syndrome: use of data from the Nevada State Cancer Registry.

Authors:  P H Levine; M Atherton; T Fears; R Hoover
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079

9.  A comparison of criteria to identify inflammatory breast cancer cases from medical records and the Surveillance, Epidemiology and End Results data base, 2007-2009.

Authors:  Kelly A Hirko; Amr S Soliman; Mousumi Banerjee; Julie Ruterbusch; Joe B Harford; Sofia D Merajver; Kendra Schwartz
Journal:  Breast J       Date:  2013-12-26       Impact factor: 2.431

10.  Mouse mammary tumor virus (MMTV)-like DNA sequences in the breast tumors of father, mother, and daughter.

Authors:  Polly R Etkind; Alexandre Fr Stewart; Peter H Wiernik
Journal:  Infect Agent Cancer       Date:  2008-02-28       Impact factor: 2.965

View more
  5 in total

1.  Bisphenol A activates EGFR and ERK promoting proliferation, tumor spheroid formation and resistance to EGFR pathway inhibition in estrogen receptor-negative inflammatory breast cancer cells.

Authors:  Scott J Sauer; Michael Tarpley; Imran Shah; Akshay V Save; H Kim Lyerly; Steven R Patierno; Kevin P Williams; Gayathri R Devi
Journal:  Carcinogenesis       Date:  2017-03-01       Impact factor: 4.944

2.  Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells.

Authors:  Evan N Cohen; Hui Gao; Simone Anfossi; Michal Mego; Neelima G Reddy; Bisrat Debeb; Antonio Giordano; Sanda Tin; Qiong Wu; Raul J Garza; Massimo Cristofanilli; Sendurai A Mani; Denise A Croix; Naoto T Ueno; Wendy A Woodward; Raja Luthra; Savitri Krishnamurthy; James M Reuben
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

3.  Space-time analysis of testicular cancer clusters using residential histories: a case-control study in Denmark.

Authors:  Chantel D Sloan; Rikke B Nordsborg; Geoffrey M Jacquez; Ole Raaschou-Nielsen; Jaymie R Meliker
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

4.  Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference.

Authors:  Wendy A Woodward; Massimo Cristofanilli; Sofia D Merajver; Steven Van Laere; Lajos Pusztai; Francois Bertucci; Fedor Berditchevski; Kornelia Polyak; Beth Overmoyer; Gayathri R Devi; Esta Sterneck; Robert Schneider; Bisrat G Debeb; Xiaoping Wang; Kenneth L van Golen; Randa El-Zein; Omar M Rahal; Angela Alexander; James M Reuben; Savitri Krishnamurthy; Anthony Lucci; Naoto T Ueno
Journal:  J Cancer       Date:  2017-10-09       Impact factor: 4.207

5.  Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study.

Authors:  Roxana Moslehi; Elizabeth Freedman; Nur Zeinomar; Carmela Veneroso; Paul H Levine
Journal:  BMC Cancer       Date:  2016-05-26       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.